4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-23-001588
CHIEF EXECUTIVE OFFICER bought 10,000 shares at $3.37 ($33,700)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2023-03-10 | Purchase | +10,000 | $3.37 | $33,700 | 6,021,873 | D |
| Open-market purchases · 10,000 sh · avg $3.37 · $33,700 | |||||||
Loading xslF345X03/ownership.xml…